Navigation Links
Immucor Schedules Fiscal 2009 Guidance Call
Date:5/28/2008

NORCROSS, Ga., May 28 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced it expects to release its fiscal 2009 guidance on Wednesday, June 4, 2008, after the close of regular trading hours, and then host a conference call on Thursday, June 5, 2008 at 8:30 AM (EDT) to discuss expectations for fiscal 2009. Investors are invited to participate in this conference call with Dr. Gioacchino De Chirico, President and Chief Executive Officer, Richard A. Flynt, Chief Financial Officer, and Edward L. Gallup, consultant. The release will be posted on Immucor's website, as well as any material financial information that may be discussed by Dr. De Chirico, Mr. Flynt or Mr. Gallup during this call not contained in the release. Both the release and the additional financial information, if any, will be posted as soon as practicable after the call on the investor news section of Immucor's website. To access this information once posted, go to Immucor's website at http://www.immucor.com and click on "About Us - Press Releases."

To participate in the telephone conference call, dial 1-888-829-8668 and passcode BLUD. Replays of the conference call will be available for one week beginning at 12:00 noon on June 5, 2008 by calling 1-866-508-6479. Beginning June 12, 2008, audio of the conference call or a transcript of the audio will be available on the "About Us - Press Releases" page of the Immucor website.

For more information on Immucor, please visit our website at http://www.immucor.com.

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Im
'/>"/>

SOURCE Immucor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Immucor Schedules First Quarter Earnings Release and Conference Call
2. Immucor Announces Record Fiscal First Quarter Revenues
3. Immucor, Inc. Appoints New Chief Financial Officer
4. Immucor Announces Update to Second Quarter Conference Call Number
5. Immucor, Inc. Adds Director to Board
6. Immucor Schedules Third Quarter Earnings Release and Conference Call
7. Immucor Announces Record Fiscal Third Quarter Results
8. Immucor Responding to FDA Warning Letter
9. Roper Industries Schedules Third Quarter 2007 Financial Results Conference Call
10. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
11. Omnicell Schedules Third Quarter Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Spring is the perfect time to ... filled with whole foods to weather perfect for outdoor ... season the nutrition experts at Brilliant Nutrition highlight five ... , 1. Eating Locally, With the abundance of fresh ... and explore, spring is a great time to take ...
(Date:5/21/2013)... Feed additives have now become an ... chain. Most of the feed additives are used in ... and powders. There are variety of feed additives available ... upon the type of animal and feed. Nutritional feed ... essential nutrition to the animal in order to gain ...
(Date:5/21/2013)... Daily Gossip Magazine published well-documented articles that are ... people informed on the latest weight loss methods by publishing ... in-depth review of Kyle Leon’s Customized Fat ... want to lose weight or stay in shape with the ... was created by a popular fitness trainer, Kyle Leon, who ...
(Date:5/21/2013)... DISCcert has served the training industry for ... DISC applications at the July 25 & 26th ... July 25 & 26th DISC certification in San Diego, ... DISC. The time-tested, proven support materials will include valuable ... training materials ; worksheets, handouts, learning activities, power-points ...
(Date:5/21/2013)... 2013) Prostaglandin analogues (PGAs), drugs which lower intraocular ... people with glaucoma, but their use is not without ... dryness, changes in eye color and other side effects. ... also cause upper and lower eyelid drooping and other ... described in PLOS ONE . , Researchers from ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:Glaucoma drug can cause droopy eyelids 2
... Inc. (Nasdaq: MSON ), a developer of ... is used for the ablation of tumors and worldwide ... has purchased three patents associated with High Intensity Focused ... relate to HIFU transducer arrays method of fabrication, ultrasonic ...
... with rheumatic diseases want more information and better communication ... their conditions, according to the results of a new ... of the European League Against Rheumatism in Copenhagen, Denmark. ... understand the importance of addressing sexual health with their ...
... Friday 12 June 2009: After five years of receiving ... spondylitis (AS) showed substantial clinical benefit (ASAS40, ASsessment in ... at five years, 78.4% of AS patients had no ... junction between tendon and bone). Over this period, patients ...
... CHICAGO, June 12 Germany ... by the eastern federal states.,This is in large part ... despite the economic crisis. American investor interest in,Germany remains ... Nordex AG shared their success stories at the "How,Far ...
... , Travelers Turn to InsureMyTrip.com for Coverage Protection and ... Stating ,the scientific criteria for an influenza pandemic have ... declared the A(H1N1) virus, commonly referred to as Swine ... http://www.newscom.com/cgi-bin/prnh/20070529/NETU076LOGO ) , , "Particularly ...
... 12 June 2009: 92.8% of patients with systemic lupus ... both their physical and emotional quality of life (QoL), ... today at EULAR 2009, the Annual Congress of the ... analysis revealed that depression was the most significant factor ...
Cached Medicine News:Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 3Health News:Better access to info and dialogue with HCPs on sexual issues for rheumatology patients 2Health News:Better access to info and dialogue with HCPs on sexual issues for rheumatology patients 3Health News:IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS 2Health News:IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS 3Health News:American Investors Highlight Successes in Eastern Germany 2Health News:World Health Organization Declares A(H1N1) Pandemic 2Health News:World Health Organization Declares A(H1N1) Pandemic 3Health News:Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients 2
(Date:5/21/2013)... 21, 2013  BioRestorative Therapies, Inc. ("BRT" or the ... on developing stem cell based therapies for various personal ... its President and CEO, will be presenting at the ... be held on Thursday, May 30, 2013 at the ... in New York City.  Mr. Weinreb,s presentation will take ...
(Date:5/21/2013)... , May 21, 2013 Ceregene, ... secondary analysis of its double-blind, randomized, controlled Phase ... a gene therapy product designed to deliver the ... analysis identified a more robust response to CERE-120 ... to treatment relative to those diagnosed 10 years ...
(Date:5/21/2013)... MONROVIA, Calif. , May 21, 2013 ... leading developer, manufacturer and marketer of minimally invasive ophthalmic ... upcoming investor conferences to review the Company,s recent financial ... STAAR Surgical will present at the 38 ... Boston at the Westin Waterfront ...
Breaking Medicine Technology:BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5STAAR Surgical To Present At Upcoming Investor Conferences 2
... COLLEGEVILLE, Pa., and TARRYTOWN, N.Y., May 22 ... ), and Progenics,Pharmaceuticals, Inc. (Nasdaq: PGNX ), ... with investigational oral and,intravenous formulations of RELISTOR(TM) (methylnaltrexone ... phase 2 trial, evaluated the effects of,an oral ...
... LAS VEGAS, May 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... Christopher Moore to be the sponsor and general,partner of ... of,$1 million and up to $10 million of the ... am extremely impressed with CVBT,s wound healing drug, which ...
Cached Medicine Technology:Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 2Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 3Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 4Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 5Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 6Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations 7Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3
... Adjustable Post-Operative Pin Knee Brace (POP) for ... associated with ACL, PCL, MCL, and LCL ... extension in 7 increments. Can be locked ... increases compliance. Breakaway hinge bar converts long ...
... The Aircast Patellar Brace is a ... unique "horseshoe" shaped aircell stabilizes the patella ... maintain the position of the patella. During ... helping to reduce swelling and pain. A ...
... Pediatric Knee/Elbow Cryo/Cuff is specifically designed to treat ... the therapeutic benefits of controlled compression to minimize ... Due to the unique design of the cuff, ... knee and elbow of the patient. The Pediatric ...
... therapeutic benefits of controlled compression to minimize hemarthrosis ... cuff is anatomically designed to completely fit the ... available in three sizes for adults and is ... children 1 - 7 years of age. A ...
Medicine Products: